Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ELF
ELF logo

ELF Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy elf Beauty Inc (ELF) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
55.660
1 Day change
0.85%
52 Week Range
150.990
Analysis Updated At
2026/05/08
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

ELF is not a good buy right now for a Beginner investor focused on long-term holding. The business is still growing strongly, but the stock’s trend is weak, analyst targets are falling, insiders are selling heavily, and options sentiment is only mildly constructive. For an inpatient investor, this is not an attractive entry today.

Technical Analysis

Price closed at 61.65, slightly below the 61.79 reference, with the stock trading under its pivot at 63.07. The trend is bearish: SMA_200 > SMA_20 > SMA_5, which confirms downside structure. MACD histogram is negative at -0.0555 and still contracting, showing momentum weakness. RSI_6 at 45.68 is neutral, so there is no oversold buy signal. Support is near 59.73 and resistance at 66.41, meaning the stock is sitting closer to support than breakout territory, but the current setup is still not a clear bullish reversal.

Options Data

Bullish
Open Interest Put-Call Ratio
Neutral
Option Volume Put-Call Ratio

Options sentiment is mixed-to-slightly bullish on positioning, with open interest put-call ratio below 1 at 0.69 and volume put-call ratio near neutral at 0.96. However, implied volatility is elevated at 81.34 with IV percentile 88.05 and IV rank 77.35, suggesting the market expects large price swings. Call open interest is higher than put open interest, which leans positive, but the overall options picture is not strong enough to override the weak technical trend and falling analyst sentiment.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
4

Positive Catalysts

  • ["Q3 2026 financials showed strong growth: revenue up 37.76% YoY, net income up 128.12% YoY, and EPS up 116.67% YoY.", "Revenue and earnings acceleration indicate the core business is still expanding.", "Several analysts still maintain Buy/Overweight ratings despite reducing targets.", "Option positioning remains somewhat constructive with put-call open interest below 1."]

Neutral/Negative Catalysts

  • ["Morgan Stanley downgraded ELF to Equal Weight and cut its target to $67 from $80, citing market share losses and pressure from smaller brands.", "A broad cluster of analysts have sharply lowered price targets over the past month, signaling weakening Street conviction.", "Insiders are selling, and selling increased 3611.29% over the last month.", "Hedge funds are neutral with no significant accumulation trend.", "News includes a fiduciary duty investigation by Halper Sadeh LLC, creating a governance overhang.", "Technical trend remains bearish with MACD negative and moving averages stacked bearishly.", "The stock is near but still below pivot resistance, not in a confirmed rebound.", "No AI Stock Picker or SwingMax signal is present today."]

Financial Performance

Latest quarter shown is Q3 2026. Revenue rose to $489.5M, up 37.76% YoY, net income increased to $39.4M, up 128.12% YoY, and EPS rose to $0.65, up 116.67% YoY. Gross margin slipped slightly to 70.99%, down 0.42% YoY. Overall, the latest quarter was very strong on growth and profitability, with only a mild margin decline.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment has turned more cautious. Morgan Stanley downgraded the stock to Equal Weight and cut its target to $67, while Baird, TD Cowen, JPMorgan, Citi, BofA, UBS, and Evercore all reduced targets recently. Some firms still keep Buy/Outperform ratings, but the overall trend is clearly toward lower price targets and more concern about market share pressure, margin risk, and softer forward outlook. Wall Street pros are still split, but the balance of opinion has become less favorable.

Wall Street analysts forecast ELF stock price to rise
15 Analyst Rating
Wall Street analysts forecast ELF stock price to rise
12 Buy
3 Hold
0 Sell
Strong Buy
Current: 55.190
sliders
Low
85
Averages
112.21
High
136
Current: 55.190
sliders
Low
85
Averages
112.21
High
136
Morgan Stanley
Overweight -> Equal Weight
downgrade
$80 -> $67
AI Analysis
2026-05-01
Reason
Morgan Stanley
Price Target
$80 -> $67
AI Analysis
2026-05-01
downgrade
Overweight -> Equal Weight
Reason
Morgan Stanley downgraded Elf Beauty to Equal Weight from Overweight with a price target of $67, down from $80. The company's market share losses in its core cosmetics business are concerning and "poised to worsen" as the summer of 2025 pricing cycles, the analyst tells investors in a research note. The firm believes Elf is seeing "durable pressure" from smaller brands as the cosmetics category fragments. As a result, Elf's compressed valuation looks "reasonable" even after stock's underperformance, contends Morgan Stanley.
Baird
Outperform
to
NULL
downgrade
$115 -> $90
2026-04-28
Reason
Baird
Price Target
$115 -> $90
2026-04-28
downgrade
Outperform
to
NULL
Reason
Baird lowered the firm's price target on Elf Beauty to $90 from $115 and keeps an Outperform rating on the shares. The firm updated its model ahead of Q4 results.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ELF
Unlock Now

People Also Watch